GET THE APP

P-CHECK: A safety checklist for a chronic pain service | 5377
Journal of Developing Drugs

Journal of Developing Drugs
Open Access

ISSN: 2329-6631

+44 1478 350008

P-CHECK: A safety checklist for a chronic pain service


4th International Summit on GMP, GCP & Quality Control

October 26-28, 2015 Hyderabad, India

Emanuele Piraccini

Morgagni Pierantoni Hospital, Italy

Posters-Accepted Abstracts: J Develop Drugs

Abstract :

The P-Check (Pain Checklist) is a patient safety tool used in our pain service for outpatient procedures. It has been created to decrease the incidence of human factors related adverse events for pain therapy procedures. It is composed by 12 items, 5 must be checked when the patient gets in the ambulatory, while 7 must be checked immediately before the procedure. The first 5 items to check are patient��?s identity, procedure scheduled and blood tests needed, availability of tools needed for the procedure and adverse events management, patient��?s awareness on the procedure, written informed consent. The last 7 items are injection site, allergy, anti-coagulation or platelet aggregation inhibitors use, hypertension or diabetes disease, correct position of the patient for the procedure, hands wash, and sterile procedure. We are going to record adverse and near misses events and compare their incidence with our data regarding these events before the P-Check use. Most of our procedures involve corticosteroid injection (i.e., facet joint or epidural), we will record the following adverse events: Abnormal hypertension (increase in blood pressure values with clinical symptoms), abnormal glycaemia (increase in glycaemia with need to change anti-diabetic therapy), bleeding during or after the injection, allergic reaction, infections in the injection site. The near misses events are: Injections performed without written informed consent, corticosteroid dose not reduced in patients suffering by diabetes or hypertension, injection in patient using anti coagulation or platelet aggregation inhibitors without the scheduled safety equipment (i.e., ultrasound machine), wrong injection site.

Biography :

Email: drpiraccini@gmail.com

Top